Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.22
0.00 (0.00%)
USD |
NASDAQ |
Oct 30, 16:00
4.23
+0.01
(+0.24%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Cash from Investing (Quarterly) : 18.26M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.26M |
| March 31, 2026 | 22.46M |
| December 31, 2025 | -57.14M |
| September 30, 2025 | 19.64M |
| June 30, 2025 | 17.74M |
| March 31, 2025 | 18.12M |
| December 31, 2024 | 8.73M |
| September 30, 2024 | -15.36M |
| June 30, 2024 | -16.44M |
| March 31, 2024 | -98.24M |
| December 31, 2023 | 10.39M |
| September 30, 2023 | 10.90M |
| June 30, 2023 | 8.808M |
| March 31, 2023 | 5.550M |
| December 31, 2022 | 11.78M |
| September 30, 2022 | -5.971M |
| June 30, 2022 | -18.70M |
| March 31, 2022 | 42.96M |
| December 31, 2021 | -3.177M |
| September 30, 2021 | 0.2841M |
| June 30, 2021 | -13.10M |
| March 31, 2021 | -57.42M |
| December 31, 2020 | 0.0521M |
| September 30, 2020 | -0.0568M |
| June 30, 2020 | -0.0162M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.4636M |
| December 31, 2019 | -1.292M |
| September 30, 2019 | -1.194M |
| June 30, 2019 | -0.1833M |
| March 31, 2019 | -0.0736M |
| December 31, 2018 | -0.2498M |
| September 30, 2018 | -0.1058M |
| June 30, 2018 | -0.6752M |
| March 31, 2018 | -1.270M |
| December 31, 2017 | -0.5802M |
| September 30, 2017 | -0.0454M |
| June 30, 2017 | -0.0417M |
| March 31, 2017 | -0.0401M |
| December 31, 2016 | -0.096M |
| September 30, 2016 | -0.0699M |
| June 30, 2016 | -0.1218M |
| March 31, 2016 | -0.0653M |
| December 31, 2015 | -0.093M |
| September 30, 2015 | -0.0048M |
| June 30, 2015 | -0.0145M |
| March 31, 2015 | -0.0017M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0564M |
| June 30, 2014 | |
| March 31, 2014 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -3.265M |
| Tonix Pharmaceuticals Holding Corp. | -0.5769M |
| Karyopharm Therapeutics, Inc. | -10.04M |
| Minerva Neurosciences, Inc. | -4.833M |
| Ocugen, Inc. | -0.021M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.63M |
| Cash from Financing (Quarterly) | 9.075M |
| Free Cash Flow | -86.69M |
| Free Cash Flow Per Share (Quarterly) | -1.527 |
| Free Cash Flow to Equity (Quarterly) | -32.69M |
| Free Cash Flow to Firm (Quarterly) | -29.63M |
| Free Cash Flow Yield | -122.8% |